Breast cancer
Results
Phase 3
This trial compared bevacizumab plus chemotherapy with chemotherapy alone, before surgery for early stage breast cancer.
Breast cancer cells often have receptors for a protein called HER2. If there are only small numbers of receptors for the HER2 protein, the cancer is called . This trial was for women with HER2 negative breast cancer that hadn’t spread. The trial was supported by Cancer Research UK.
Recruitment start: 1 April 2009
Recruitment end: 31 January 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Helena Earl
Dr Larry Hayward
Cambridge University Hospitals NHS Foundation Trust
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Roche
Sanofi
University of Cambridge
University of Edinburgh
University of Warwick
This is Cancer Research UK trial number CRUK/08/037.
Last reviewed: 21 May 2019
CRUK internal database number: 3849
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
